GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment

Xiaoxin Liang, Shilin Lu, Liang Yang, Jianhua Zhou, Fei Yan

Open source

DOI
10.1016/j.mtbio.2026.103659
Published
2026-10
Container
Materials Today Bio
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.mtbio.2026.103659,
  title = {GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment},
  author = {Xiaoxin Liang and Shilin Lu and Liang Yang and Jianhua Zhou and Fei Yan},
  year = {2026},
  journal = {Materials Today Bio},
  doi = {10.1016/j.mtbio.2026.103659},
  url = {https://doi.org/10.1016/j.mtbio.2026.103659}
}

RIS

TY  - JOUR
TI  - GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment
AU  - Xiaoxin Liang
AU  - Shilin Lu
AU  - Liang Yang
AU  - Jianhua Zhou
AU  - Fei Yan
PY  - 2026
JO  - Materials Today Bio
DO  - 10.1016/j.mtbio.2026.103659
UR  - https://doi.org/10.1016/j.mtbio.2026.103659
ER  - 

APA

Liang, X., Lu, S., Yang, L., Zhou, J., & Yan, F. (2026). GV21 enables ultrasound molecular imaging of tumor cell-associated VEGFR2 for early therapy assessment. Materials Today Bio. https://doi.org/10.1016/j.mtbio.2026.103659

Source records